-
1Academic Journal
Συγγραφείς: Боднар, O., Паламарюк, B., Палагнюк, B.
Πηγή: Clinical anatomy and operative surgery; Vol. 4 No. 2 (2005); 64-65
Клиническая анатомия и оперативная хирургия; Том 4 № 2 (2005); 64-65
Клінічна анатомія та оперативна хірургія; Том 4 № 2 (2005); 64-65Θεματικοί όροι: алотрансплантація нирки, ішемія, інтраопераційна перфузія, аллотрансплантация почки, ишемия, интраоперационная перфузия, kidney аllografting, ischemia, intraoperative рerfusion, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://kaos.bsmu.edu.ua/article/view/259652
-
2Academic Journal
Συγγραφείς: R. R. Nuriakhmetov, V. S. Panteleev, A. R. Zagitov, M. A. Nartailakov, M. N. Kornilov, I. I. Biganyakov
Πηγή: Креативная хирургия и онкология, Vol 12, Iss 1, Pp 61-66 (2022)
Θεματικοί όροι: трансплантация почки, аллотрансплантация, covid-19, коронавирусная инфекция, sarscov-2, вирусная пневмония, иммуносупрессия, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Relation: https://www.surgonco.ru/jour/article/view/676; https://doaj.org/toc/2307-0501; https://doaj.org/toc/2076-3093; https://doaj.org/article/97b0294a4f17402a9f1043952cdea2f7
-
3Academic Journal
Συγγραφείς: Khryshchanovich, V. Y., Vershinin, P. Y., Bolshov, A. V., Tretyak, S. I., Kuzmenkova, E. I., Pisarenko, A. M., Khodosovskaya, E. V., Kolesnikova, T. S., Rummo, O. O.
Πηγή: Novosti Khirurgii. :44-52
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, АЛЛОТРАНСПЛАНТАЦИЯ ПАРАТИРОЦИТОВ,ПОЧЕЧНЫЙ ТРАНСПЛАНТАТ,ИНТЕНСИВНАЯ ЗАМЕСТИТЕЛЬНАЯ ТЕРАПИЯ,ПОСЛЕОПЕРАЦИОННЫЙ ГИПОПАРАТИРЕОЗ,ГИПЕРПЛАЗИРОВАННАЯ ПАРАТИРЕОИДНАЯ ТКАНЬ,ИММУНОСУПРЕССИВНАЯ ТЕРАПИЯ,ПОСЛЕОПЕРАЦИОННЫЕ ОСЛОЖНЕНИЯ,PARATHYROID CELLS ALLOTRANSPLANTATION,KIDNEY TRANSPLANT,INTENSIVE SUBSTITUTION THERAPY,SURGICAL HYPOPARATHYROIDISM,HYPERPLASTIC PARATHYROID TISSUE,IMMUNOSUPPRESSIVE THERAPY,POSTOPERATIVE COMPLICATIONS
Περιγραφή αρχείου: text/html; application/pdf
Σύνδεσμος πρόσβασης: http://www.surgery.by/pdf/full_text/2017_1_7_ft.pdf
https://cyberleninka.ru/article/n/allotransplantation-of-cultured-parathyroid-cells-from-a-living-unrelated-donor-to-a-kidney-transplant-recipient-the-first-clinical
http://cyberleninka.ru/article_covers/16983969.png
http://cyberleninka.ru/article/n/allotransplantation-of-cultured-parathyroid-cells-from-a-living-unrelated-donor-to-a-kidney-transplant-recipient-the-first-clinical -
4Academic Journal
Συγγραφείς: Nikolaieva, O. V., Petrov, S. A.
Πηγή: Medical and Clinical Chemistry; No. 1 (2019); 80-86 ; Медицинская и клиническая химия; № 1 (2019); 80-86 ; Медична та клінічна хімія; № 1 (2019); 80-86 ; 2414-9934 ; 2410-681X ; 10.11603/mcch.2410-681X.2019.v0.i1
Θεματικοί όροι: allotransplantation, muscle tissue, embryonic tissue, total antioxidant activity, oxidative stress, аллотрансплантация, мышечная ткань, эмбриональная ткань, общая антиоксидантная активность, оксидативный стресс, алотрансплантація, м’язова тканина, ембріональна тканина, агальна антиокси- дантна активність, оксидативний стрес
Περιγραφή αρχείου: application/pdf
Relation: https://ojs.tdmu.edu.ua/index.php/MCC/article/view/10009/9591; https://ojs.tdmu.edu.ua/index.php/MCC/article/view/10009
-
5Academic Journal
Συγγραφείς: A. V. Yarikov, A. P. Fraerman, V. A. Leonov, O. A. Perlmutter, S. E. Tikhomirov, A. V. Yaksargin, P. V. Smirnov, А. В. Яриков, А. П. Фраерман, В. А. Леонов, О. А. Перльмуттер, С. Е. Тихомиров, А. В. Яксаргин, П. В. Смирнов
Πηγή: Creative surgery and oncology; Том 9, № 4 (2019); 278-284 ; Креативная хирургия и онкология; Том 9, № 4 (2019); 278-284 ; 2076-3093 ; 2307-0501 ; 10.24060/2076-3093-2019-9-4
Θεματικοί όροι: аллотрансплантация, cranial fractures, neurosurgery, reconstructive surgical procedures, graft modelling, 3D printing, autograft transplantation, allograft transplantation, переломы черепа, нейрохирургия, реконструктивные хирургические операции, моделирование трансплантата, трехмерная печать, аутотрансплантация
Περιγραφή αρχείου: application/pdf
Relation: https://www.surgonco.ru/jour/article/view/435/367; Копорушко Н.А., Ступак В.В., Мишинов С.В., Орлов К.Ю., Астраков С.В., Вардосанидзе В.К. и др. Этиология и эпидемиология приобретенных дефектов костей черепа, полученных при различной патологии центральной нервной системы, и число больных, нуждающихся в их закрытии, на примере крупного промышленного города. Современные проблемы науки и образования. 2019;(2):120.; Синбухова Е.В., Кравчук А.Д., Чобулов С.А. Эмоциональное состояние пациента на этапе реконструктивной хирургии. Вятский медицинский вестник. 2017;(2):85–7.; Лихтерман Л.Б., Потапов А.А., Клевно В.А., Кравчук А.Д., Охлопков В.А. Последствия черепно-мозговой травмы. Судебнаямедицина. 2016;2(4):4–20. DOI:10.19048/2411-8729-2016-2-4-4-20; Семенова Ж.Б., Маршинцев А.В. Нейронавигация в реконструктивной хирургии гигантского дефекта черепа после декомпрессивной краниэктомии. Нейрохирургия и неврология детского возраста. 2017;(4):73–9.; Ступак В.В., Мишинов С.В., Садовой М.А., Копорушко Н.А., Мамонова Е.В., Панченко А.А. и др. Современные материалы, используемые для закрытия дефектов костей черепа. Современные проблемы науки и образования. 2017;(4):38.; Багатурия Г.О. Перспективы использования 3D-печати при планировании хирургических операций. Медицина: теория и практика. 2016;1(1):26–35.; Копорушко Н.А., Ступак В.В., Мишинов С.В., Орлов К.Ю., Астраков С.В., Вардосанидзе В.К. и др. Эпидемиология и этиология приобретенных дефектов костей черепа на примере крупного промышленного города. Российский нейрохирургический журнал им. профессора А.Л. Поленова. 2019;10(S):209–10.; Дюсембеков Е.К., Исатаев Б.С., Садыкова Ж.Б., Аглаков Б.М., Ли К.Ю. Краниопластика: применение 3D-имплантов для пластики дефекта черепа. Вестник Казахского Национального медицинского университета. 2016;(4):82–92.; Кравчук А.Д., Синбухова Е.В., Потапов А.А., Степнова Л.А., Лубнин А.Ю., Данилов Г.В. и др. Клинико-нейропсихологическое исследование больных с черепно-мозговой травмой до и после реконструкции дефектов черепа. Акмеология. 2018;(4):71–82.; Синбухова Е.В., Кравчук А.Д., Лубнин А.Ю., Данилов Г.В., Охлопков В.А., Степнова Л.А. Динамика когнитивных функций у пациентов с дефектами черепа после проведения реконструктивных вмешательств. Архивъ внутренней медицины. 2017;7(2):131–8. DOI:10.20514/2226-6704-2017-7-2-131-138; Stocchetti N., Carbonara M., Citerio G., Ercole A., Skrifvars M.B., Smielewski P., et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452–64. DOI:10.1016/S1474-4422(17)30118-7; Синбухова Е.В., Степнова Л.А., Кравчук А.Д., Чобулов С.А. Психологическое состояние и когнитивные функции у пациента на этапе хирургической реконструкции костного дефекта черепа после черепно-мозговой травмы (кейс-репорт). Акмеология. 2017;(1):157–61.; Мишинов С.В., Ступак В.В., Копорушко Н.А. Краниопластика: обзор методик и новые технологии в создании имплантатов. Современное состояние проблемы. Политравма. 2018;(4):82–9.; Malcolm J.G., Rindler R.S., Chu J.K., Chokshi F., Grossberg J.A., Pradilla G., et al. Early cranioplasty is associated with greater neurological improvement: a systematic review and meta-analysis. Neurosurgery. 2018;82(3):278–88. DOI:10.1093/neuros/nyx182; Гаибов С.С.Х., Воробьев Д.П., Захарчук И.А., Захарчук Е.В. Пластика сложного гигантского дефекта черепа (клинический случай). Университетская медицина Урала. 2018:4(3):7–9.; Иванов О.В., Семичев Е.В., Шнякин П.Г., Собакарь Е.Г. Пластика дефектов черепа: от аутокости к современным биоматериалам (обзор литературы). Медицинская наука и образование Урала. 2018;19(3):143–9.; Коновалов А.Н., Пилипенко Ю.В., Элиава Ш.Ш. Технические особенности и осложнения краниопластики у пациентов после декомпрессивной трепанации черепа в остром периоде субарахноидального кровоизлияния. Вопросы нейрохирургии им. Н.Н. Бурденко. 2018;82(5):88–95. DOI:10.17116/neiro20188205188; Rosinski C.L., Chaker A.N., Zakrzewski J., Geever B., Patel S., Chiu R., et al. Autologous bone cranioplasty: a retrospective comparative analysis of frozen and subcutaneous bone flap storage methods. World Neurosurg. 2019;131:e312–20. DOI:10.1016/j.wneu.2019.07.139; Fan M.C., Wang Q.L., Sun P., Zhan S.H., Guo P., Deng W.S., et al. Cryopreservation of autologous cranial bone flaps for cranioplasty: a large sample retrospective study. World Neurosurg. 2018;109:e853–9. DOI:10.1016/j.wneu.2017.10.112; Stieglitz L.H., Fung C., Murek M., Fichtner J., Raabe A., Beck J. What happens to the bone flap? Long-term outcome after reimplantation of cryoconserved bone flaps in a consecutive series of 92 patients. Acta Neurochir (Wien). 2015;157(2):275–80. DOI:10.1007/s00701-0142310-7; Иванов В.П., Ким А.В., Хачатрян В.А. 3D-печать в краниофациальной хирургии и нейрохирургии. Опыт ФГБУ «НМИЦ им. В.А. Алмазова». Нейрохирургия и неврология детского возраста. 2018;(3):28–39.; Morton R.P., Abecassis I.J., Hanson J.F., Barber J., Nerva J.D., Emerson S.N., et al. Predictors of infection after 754 cranioplasty operations and the value of intraoperative cultures for cryopreserved bone flaps. J Neurosurg. 2016;125(3):766–70. DOI:10.3171/2015.8.JNS151390; Терещук С.В., Иванов С.Ю., Сухарев В.А. Роль аддитивных технологий в современной реконструктивной хирургии. Военномедицинский журнал. 2019;340(10):28–32.; Кравчук А.Д., Комлев В.С., Мамонов В.Е., Охлопков В.А., Баринов С.М., Федотов А.Ю. и др. Аддитивные технологии в создании индивидуальных костных структур на основе пористых и сетчатых композитов титана для протезирования дефектов черепа в реконструктивной нейрохирургии. Анналы пластической, реконструктивной и эстетической хирургии. 2017;(1):103.; Mishinov S.V., Stupak V.V., Mamonova N.V., Panchenko A.A., Krasovsky I.B., Lazurenko D.V. Methods for three-dimensional prototyping and printing in reconstructive neurosurgery Biomedical Engineering. 2017;51(2):106–10. DOI:10.1007/s10527-017-9694-7; Гаврилова Л.О., Мишинов С.В., Аронов А.М., Мамонова Е.В., Мамонова Н.В., Гриф А.М. Разработка автоматизированной информационной системы проектирования и моделирования индивидуальных имплантатов, получаемых аддитивными методами, на примере замещения дефектов черепа. Международный журнал прикладных и фундаментальных исследований. 2017;(11-2):209–13.; Mishinov S.V., Stupak V.V., Koporushko N.A., Samokhin A.G., Panchenko A.A., Krasovskii I.B., et al. Titanium patient-specific implants in reconstructive neurosurgery. Biomedical Engineering. 2018;52(3):152–5. DOI:10.1007/s10527-018-9802-3; Кравчук А.Д., Потапов А.А., Панченко В.Я., Комлев В.С., Новиков М.М., Охлопков В.А. и др. Аддитивные технологии в нейрохирургии. Вопросы нейрохирургии им. Н.Н. Бурденко. 2018;82(6):97–104. DOI:10.17116/neiro20188206197; Нагибович О.А., Свистов Д.В., Пелешок С.А., Коровин А.Е., Городков Е.В. Применение технологии 3D-печати в медицине. Клиническая патофизиология. 2017;23(3):14–22.; Мишинов С.В., Ступак В.В., Мамуладзе Т.З., Копорушко Н.А., Мамонова Н.В., Панченко А.А. и др. Использование трехмерного моделирования и трехмерной печати в обучении нейрохирургов. Международный журнал прикладных и фундаментальных исследований. 2016;(11-6):1063–7.; Потапов А.А., Коновалов А.Н., Корниенко В.Н., Кравчук А.Д., Лихтерман Л.Б., Пронин И.Н. и др. Современные технологии и фундаментальные исследования в нейрохирургии. Вестник Российской академии наук. 2015;85(4):299. DOI:10.7868/S086958731504009X; Чобулов С.А., Кравчук А.Д., Потапов А.А., Лихтерман Л.Б., Маряхин А.Д., Синбухова Е.В. Современные аспекты реконструктивной хирургии дефектов черепа. Вопросы нейрохирургии им. Н.Н. Бурденко. 2019;83(2):115–24. DOI:10.17116/neiro201983021115; Мишинов С.В., Ступак В.В., Копорушко Н.А., Панченко А.А., Красовский И.Б., Десятых И.В. Трехмерное моделирование и печать в нейрохирургии. В кн.: VIII Всероссийский съезд нейрохирургов. СПб. 2018:169.; Höhne J., Werzmirzowsky K., Ott C., Hohenberger C., Hassanin B.G., Brawanski A., et al. Outcomes of Cranioplasty with Preformed Titanium versus Freehand Molded Polymethylmethacrylate Implants. J Neurol Surg A Cent Eur Neurosurg. 2018;79(3):200–5. DOI:10.1055/s0037-1604362; Goldstein J.A., Paliga J.T., Bartlett S.P. Cranioplasty: indications and advances. Curr Opin Otolaryngol Head Neck Surg. 2013;21(4):400–9. DOI:10.1097/MOO.0b013e328363003e; Di Stefano C., Rinaldesi M.L., Quinquinio C., Ridolfi C., Vallasciani M., Sturiale C., et al. Neuropsychological changes and cranioplasty: A group analysis. Brain Inj. 2016;30(2):164–71. DOI:10.3109/02699052.2015.1090013; Morton R.P., Abecassis I.J., Hanson J.F., Barber J.K., Chen M., Kelly C.M., et al. Timing of cranioplasty: a 10.75-year single-center analysis of 754 patients. J Neurosurg. 2018;128(6):1648–52. DOI:10.3171/2016.11.JNS161917; Алексеев Д.Е., Свистов Д.В., Коровин А.Е., Гордеев А.С., Ефимов Н.С. Перспективы применения искусственных заменителей твердой мозговой оболочки при лечении дефектов черепа в мирное и военное время. Известия Российской Военномедицинской академии. 2016;35(1):26–30.; Park S.P., Kim J.H., Kang H.I., Kim D.R., Moon B.G., Kim J.S. Bone flap resorption following cranioplasty with autologous bone: quantitative measurement of bone flap resorption and predictive factors. J Korean Neurosurg Soc. 2017;60(6):749–54. DOI:10.3340/jkns.2017.0203.002; https://www.surgonco.ru/jour/article/view/435
-
6Academic Journal
Συγγραφείς: M. Sh. Khubutia, O. N. Rzhevskaya, K. E. Lazareva, М. Ш. Хубутия, О. Н. Ржевская, К. Е. Лазарева
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 2 (2009); 9-14 ; Трансплантология; № 2 (2009); 9-14 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2009-0-2
Θεματικοί όροι: пероральные сахароснижающие препараты, glucose intolerance, tacrolimus, cadaveric renal allotransplantation, pancreatic allotransplantation, glycosylated hemoglobin, oral sugar-lowering drugs, нарушение толерантности к глюкозе, такролимус, аллотрансплантация трупной почки, аллотрансплантация поджелудочной железы, гликолизированный гемоглобин
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/250/312; Hathaway D.K., Tolley E.A., Blakely M.L. et al. Development of an index to predict post-transplant diabetes mellitus. Clin Transplant 1994;7:330—8.; Friedman E.A., Shyh T., Beyer M.M. et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985;5: 196—202.; Vincenti F., Friman S., Scheuermann E. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transp 2007;7:1506—14.; Howard A. Management of new-onset diabetes mellitus in the kidney transplant recipient. Medscape Transplant 2004; 14 Jul.; Thomas M.C, Moran J., Mathew T.H. et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrology 2000;1:1.; Pourmand G., Ebrahimi M.R., Mehrsai A.R., Taheri M. Patient blood glucose levels before and after kidney transplantation. Transplant Proc 2000;32(3):566—8.; Min C., Kang E., Yu S.H. et al. Advanced glycation end products induce apoptosis and pro-coagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract 1999;46(3): 197—202.; Pavlovic D., Van de Winkel M., Van der Auwera B. et al. Effect of interferongamma and glucose on major histo-compatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 1997;82(7):2329—36.; Foster K.J., Alberti K.G., Binder C. et al. Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg 1979;66(4):242—5.; Spencer C.M., Goa K.L., Gillis J.C. Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997;54: 925—75.; Jindal R.M., Sidner R.A., Milgrom M.L. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997;16: 242—57.; Pirsch J.D., Miller J., Deierhoi M.H. et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997;63:977—83.; Cavaille-Coll M.W., Elashoff M.R. Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1998;65:142—3.; Marchetti P., Navalesi R. The metabolic effects of cyclosporine and tacrolimus. J Endocrinol Invest 2000;23:482—90.; Heisel O., Heisel R., Balshaw R., Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004;4;583—95.; Jain A., Khanna A., Molmenti E.P. et al. Immunosuppressive therapy. Surg Clin North Am 1999;79:59—76.; Johnson C., Ahsan N., Gonwa T. et al. Randomized trial of tacrolimus in combination with azathioprine or mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000;63;834—41.; Lazzaro C., McKechnie T., McKenna M. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses. J Nephrol 2002;15:580—8.; Vincenti F., Jensik S.C., Filo R.S. et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002;73:775—82.; Weir M.R., Fink J.C. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999;34:1—13.; Hirano Y., Fujihira S., Ohara K. et al. Morphological and functional changes of islets of Langherans in FK506-treated rats. Transplantation 1992;53:889—94.; Martin F., Bedoya F.J. Mechanisms of action of cyclosporine A on islet alfa-and beta cells. Effects on cAMP and calcium dependent pathways. Life Sci 1991;49:1915—21.; Redmond J.B., Olson L.K., Armstrong M.B. et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996;98: 2786—93.; Ishizuka J., Guiuzza K.K., Wassmuth Z. et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islet. Transplantation 1993;56:1486—90.; Noguchi N., Takasawa S., Nata K. et al. Cyclic ADP-ribose binds to FK506 binding protein 12.6 to release calcium++ from islet microsome. J Biol Chem 1997;272:3133—6.; Lanerolle R.D., de Abrew K., Fernando D.J., Sheriff M.H. Posttransplant diabetes in Sri Lanka. Transplant Proc 1996;28:1945—7.; Berwerck S., Kahl A., Bechstein W. et al. Clinical use of the euglicemic hyperinsulinemic clamp for diagnosis of tacrolimusinduced insulin resistance after combined pancreas-kidney transplantation. Transplant Proc 1998;30:1944—5.; Basadonna G., Montorsi F., Dakizaki K., Merrell R.C. Cyclosporine A and islet function. Am J Surg 1988;156:191—3.; Bani Sacchi T., Bani D., Filipponi F. et al. Immunocytochemical and ultra structural changes of islet cells in rats treated longterm with cyclosporine at immunotherapeutic doses. Transplantation 1990;49:982—7.; Van Hoff J.P., Christiaans M.H., Ven Duijnhoven E.M. et al. Glucose metabolic disorder after transplantation. Am J Transplant 2007;7:1435—6.; Ciancio G., Burke G., Gaynor J. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 2004;77:252—8.; Maes B.D., Kuypers D., Messian T. et al. Post-transplan-tation diabetes mellitus in FK506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001;72:1655—61.; Pagano G., Cavalco-Perin P., Cassader M. et al. An in vivo and in vitro study of the mechanism of prednisoneinduced insulin resistance in healthy subjects. J Clin Invest 1983;72:1814—20.; Shapiro R., Jordan M.L., Scantlebury V.P. et al. A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/prednisone in renal transplant patients. Transplant Proc 1995;27:814—7.; Christiansen E., Andersen H., Rasmusse K. et al. Pancreatic b-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am Physiol Soc 1993;264(3):441—9.; Andrews R.C., Wolker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999;96:513—23.; Henriksen J.E., Alford F., Ward G.M., Beck-Nielsen H. Risk and mechanism for dexamethazone-induced deterioration of glucose tolerance in non-diabetic first degree relatives of NIDDM patients. Diabetologia 1997;40:1439—48.; Hjelmesaeth J., Hartmann A., Kosstad J. et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64:979—83.; Jawad F., Rizvi S.A. Post-transplant diabetes mellitus in live-re-lated renal transplantation. Transplant Proc 2000;32:1888.; Boots J.M., Van Duijnhoven E.M., Christiaans M.H. et al. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002;13:221—7.; Vanrenterghem Y. Strategies to reduce or replace steroid dosing. Transplant Proc 1999;31 (Suppl 8A):7—10.; Christiansen E., Tibell A., Volund A.A. et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997;82:2299—307.; Gruessner R.W. Tacrolimus in pancreas transplantation: a multi-center analysis. Tacrolimus Pancreas Study Group. Clin Transplant 1997;11:299—312.; Gruessner R.W., Burke G.W., Stratta R. et al. A multi-center analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996;61:261—73.; Sumrani N.B., Delaney V., Ding Z. et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 1991;51:343—7.; Rao M., Jacob C.K., Shastry J.C. Post-renal transplant diabetes mellitus: a retrospective study. Nephrol Dial Transplant 1992;7:1039—42.; Keen H., Jarret R.J., Mc Cartney P. The ten-year follow-up of the Bedford survey (1962—1972): glucose tolerance and diabetes. Diabetologia 1982;22:73—8.; Vesco L., Busson M., Bedrossian J. et al. Diabetes mellitus after renal transplantation. Transplantation 1996;61:1475—8.; Kasiske B.L., Sneyder J.J., Gilbertson D., Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2002;2(Suppl 3):225.; Knoll G.A., Bell R.C. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. Br Med J 1999;318:1104—7.; Parikh C., Klem P., Wong C., Chan L. Obesity as an independent predictor of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2(Suppl 3):420.; De Mattos A.M., Prather J., Al-Uzri A. et al. Autosomal dominant polycystic kidney disease (ADPKD) as risk factor for the development of posttransplant diabetes mellitus (PTDM). Am J Transplant 2002;2:359.; Cosio F.G., Pesavento T.E., Kim S. et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440—6.; Revanur V.K., Jardine A.G., Kingsmore D.B. et al. Influence of diabetes mellitus on patients and graft survival in recipients of kidney transplantation. Clin Transplant 2001;15:89—94.; Thomas M.C., Mathew P.H., Russ G.R. et al. Early perioperative glycemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001;72:1321—4.; Klahr S., Levey A.S., Beck G.J. et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 1994;330:877—84.; Noble N.A., Border W.A. Angiotensin II in renal fibrosis. Should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 1997;17:455—66.; Miles A.M., Sumrani N., Horowitz R. et al. Diabetes mellitus after renal transplantation. Transplantation 1998;65:380—4.; Schneider D.J., Nordt T.K., Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993;42:1—7.; Maser R.E., Wolfson S.K. Jr., Ellis D. et al. Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb 1991;11:958—65 [Abstract].; Laakso M., Pyorala K., Scarlund H., Voutilainen E. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus. Arteriosclerosis 1986;6:679— 84 [Abstract].; Raine A.E.G. Cardiovascular complications after renal transplantation. In: P.J. Morris (ed.). Kidney transplantation: principles and practice. Philadelphia: PA, Saunders; 1988. p. 575—601.; Hjelmeseth J., Hartmann A., Midvedt K. et al. Metabolic cardiovascular syndrome after renal Transplantation. Nephrol Dial Transplant 2001;16:1047—52.; Von Kiparsky A., Frei D., Uhlschmid G. et al. Post-transplant diabetes mellitus in renal allograft recipients: a matched pair control study. Nephrol Dial Transplant 1990;5:220—5.; Chiu M.Y., Sprague S.M., Bruce D.S. et al. Analysis of fracture prevalence in kidneypancreas allograft recipients. J Am Soc Nephrol 1998;9:677—83.; Marchetti P. Strategies for risk reduction and management of post-transplant diabetes mellitus. Transplant Proc 2001;33(Suppl 5A):27—31.; https://www.jtransplantologiya.ru/jour/article/view/250
-
7Academic Journal
Συγγραφείς: A. V. Pinchuk, А. В. Пинчук
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1 (2011); 5-12 ; Трансплантология; № 1 (2011); 5-12 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2011-0-1
Θεματικοί όροι: нейропатия, pancreas, diabetes mellitus, immunosuppression, survival, поджелудочная железа, сахарный диабет, инсулинорезистентность, сочетанная аллотрансплантация, нефропатия
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/301/362; Бергер М., Старостина Е.Г., Йоргенс В.,Дедов И. Практика инсулинотерапии. Heidelberg: Springer-Verlag, 1990; с.1-13, 25-51. 2. Трансплантология. Руководство. Подред. В.И. Шумакова. М.: Медицина, 1995; Тула: Репроникс Лтд, 1995. 391 с.; Dubernard J.M., Treaeger J., Neyra P. et al. A new metod of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery 1978;84:633-40.; Kelly W.D., Lillehei R.C., Merkel F.K. et al. Allotransplantation of the pancreas and duodenum alone with the kidney in diabetic nephropathy. Surgery;1967;61:820-7. 5. Abhinav Humar, Arthur J. Matas, William; D. Payne. Atlas of Organ Transplantation. Springer, 2006; p. 339.; Drachenberg C.B., Odorico J., Demetris A.J. et al. Banff schema for grading pancreas allograft rejection: working proposal by a multidisciplinary international consensus panel. Am J Transplant 2008;8(6):1237-49.; Sollinger H.W., Cook K., Kamps D. et al. Clinical and experimental experience with pancreaticocystostomy for exocrine pancreatic drainage in pancreas transplantation. Transplantation proceedings 1984 Jun;16(3):749-51. 8. Clinical transplants 2008. J. Michael Cecka; Paul I. Terasaki, eds. 2009; p. 550.; Sollinger H.W., Glass N.R., Southard J.H.,Belzer F.O. Current status of organ transplantation. Clinics in laboratory medicine 1983;3(4):763-78.; Fioretto P., Mauer S.M., Bilous R.W. et al. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993;342(8881):1193-6.; Secchi A., Dubernard J.M., Rocca E.L. et al. Endocrinometabolic effects of whole versus segmental pancreas alloTransplantation in diabetic patients -a two-year follow-up. Transplantation 1991;51(3):625-9.; Corry R.J., Egidi M.F., Shapiro R. et al. Enteric drainage of pancreas transplants revisited. Transplantation proceedings 1995;27(6):3048-9.; Nghiem D.D., Pitzen R.H., Corry R.J. Evaluation of techniques of controlling exocrine drainage after segmental pancreatectomy in dogs. Implications for pancreatic transplantation. Arch Surg 1985;120(10):1132-7.; Hummel R., Langer M., Wolters H.H. et al. Exocrine drainage into the duodenum: a novel technique for pancreas transplantation. Transplant int 2008;21(2):178-81.; De Roover A., Detry O., Coimbra C. et al. Exocrine pancreas graft drainage in recipient duodenum through side-to-side duodeno duodenostomy. Transplant int 2008;21(7):707.; Prieto M., Sutherland D.E., Fernandez-Cruz L. et al. Experimental and clinical experience with urine amylase monitoring for early diagnosis of rejection in pancreas Transplantation. Transplantation 1987;43(1):73-9.; Hellerström C., Andersson A., Groth C.G. et al. Experimental pancreatic transplantation in diabetes. Diabetes Care 1988;11 Suppl 1:45-53.; Drachenberg C.B., Papadimitriou J.C.,Schweitzer E. et al. Histological findings in "incidental" intraoperative pancreas allograft biopsies. Transplant Proc 2004;36(3):780-1.; Papadimitriou J.C., Drachenberg C.B.,Klassen D.K. et al. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplantation 2003;3(5):599-605.; Tydén G., Tibell A., Sandberg J. et al. Improved results with a simplified technique for pancreaticoduodenal transplantation with enteric exocrine drainage. Clin transplant 1996;10(3):306-9.; Solders G., Tydén G., Tibell A. et al. Improvement in nerve conduction 8 years after combined pancreatic and renal transplantation. Transplant Proc 1995;27(6):3091.; Solders G., Tydén G., Persson A.,Groth C.G. Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 1992;41(8):946-51.; Martin-Pagola A., Sisino G., Allende G. et al. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia 2008;51(10):1803-13. 24. Kidney and Pancreas Transplantation: a practical guide. T.R. Srinivas, Daniel A. Shoskes. Humana Prass, 2010; p. 441.; Navarro X., Sutherland D.E.,Kennedy W.R. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997;42(5):727-36.; Nghiem D.D., Gonwa T.A., Corry R.J. Metabolic effects of urinary diversion of exocrine secretions in pancreatic Transplantation. Transplantation 1987;43(1):70-3.; Nghiem D.D., Gonwa T.A., Corry R.J. Metabolic monitoring in renal-pancreatic transplants with urinary pancreatic exocrine diversion. Transplant proc 1987; 19(1 Pt 3):2350-1.; De Roover A., Coimbra C., Detry O. et al. Pancreas graft drainage in recipient duodenum: preliminary experience. Transplantation 2007;84(6):795-7.; Duck Jong Han, David E.R. Sutherland. Pancreas Transplantation. Gut and liver 2010; 4(4): 450-65.; Brons I.G., Calne R.Y. Pancreas transplan-12 tation: the Cambridge experience. Transplant proc 1987;19(4 Suppl 4):11-6.; Sollinger H.W., Kalayoglu M., Belzer F.O. Pancreas transplantation: the University of Wisconsin experience. Clin transplants 1987:103-8.; Rosenlof L.K., Earnhardt R.C.,Pruett T.L. et al. Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts. Ann Surg 1992;215(6):586-95.; Shyr Y.M. Pancreas transplantation. J Chin Med Assoc 2009;72(1):4-9.; Pancreas, islet, and stem cell transplantation for diabetes, second edition. Edited by; Nadey S. Hakim et al. OXFORD University Press, 2010; p. 526.; Munda R., Tom W.W., First M.R. et al. Pancreatic allograft exocrine urinary tract diversion. Pathophysiology. Transplantation 1987;43(1):95-9.; Lundgren G., Arnep P., Groth C.G. et al. Pancreatic transplantation for diabetes mellitus. Discussion of indications and surgical technique with reference to 3 cases. Scand J Urol Nephrol 1975;(29 Suppl):63-5.; Traeger J., Dubernard J.M., Touraine J.L. et al. Pancreatic transplantation in cases of diabetes complicated by renal insufficiency. Adv Nephrol Neck Hosp 1979;8:127-49.; Traeger J., Dubernard J.M., Touraine J.L. et al. Pancreatic transplantation in man: a new method of pancreas preparation and results on diabetes correction. Transplant proc 1979;11(1):331-5.; Pancreatic Transplantation. Edited by; Robert J. Corry, Ron Shapiro. Informa Healthcare, 2006: p. 467.; Cook K., Sollinger H.W., Warner T. et al. Pancreaticocystostomy: an alternative method for exocrine drainage of segmental pancreatic allografts. Transplantation 1983;35(6):634-6.; Starzl T.E., Iwatsuki S., Shaw B.W. Jr. et al. Pancreaticoduodenal transplantation in humans. Surg, gynecol Obstet 1984;159(3):265-72. 42. Helen Liapis, Hanlin L. Pathology of Solid Organ Transplantation. Wang.-Springer, 2009; p. 480.; Tom W.W., Munda R., First M.R.,Alexander J.W. Physiologic consequences of pancreatic allograft exocrine drainage into the urinary tract. Transplant proc 1987;19(1 Pt 3):2339-42.; Bohman S.O., Tydén G., Wilczek H. et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 1985;34(3):306-8.; Ramsay R.C., Goetz F.C., Sutherland D.E. et al. Progression of diabetic retinopathy after pancreas transplantation for insulindependent diabetes mellitus. N Engl J Med 1988;318(4):208-14.; Laughlin E., Burke G., Pugliese A. et al. Recurrence of autoreactive antigen-specific CD4+ T-cells in autoimmune diabetes after pancreas transplantation. Clin Immunol 2008;128(1):23-30.; Vendrame F., Pileggi A., Laughlin E. et al. Recurrence of type 1 Diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010;59(4):947-57.; Bohman S.O., Wilczek H., Tydén G. Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 1987;19(1 Pt 3):2290-3.; Prieto M., Sutherland D.E., Fernandez-Cruz L. Rejection in pancreas transplantation. Transplant proc 1987;19(1 Pt 3):2348-9.; Groth C.G., Lundgren G., Gunnarsson R. Segmental pancreatic transplantation with duct ligation or drainage to a jejunal Roux-en-Y loop in nonuremic diabetic patients. Diabetes 1980;29 Suppl 1:3-9.; Drachenberg C.B., Papadimitriou J.C. Spectrum of histopathological changes in pancreas allograft biopsies and relationship to graft loss. Transplant Proc 2007;39(7):2326-8.; Ishitani M.B., Rosenlof L.K., Hanks J.B.,Pruett T.L. Successful paratopic pancreas transplantation: a report of three cases with venous portal drainage and enteric exocrine drainage. Clin Transplant 1993; 7(1 part 1):28-32.; Dubernard J.M., Traeger J., Neyra P. Suppression of the exocrine function as an aid to of segmental pancreatic transplantation in dogs. Biomedicine 1977;27(4):172-4.; Corry R.J., Nghiem D.D., Schulak J.A. Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obst 1986;162(6):547-55.; Drachenberg C.B., Papadimitriou J.C. The inflamed pancreas transplant: histological differential diagnosis. Semin Diagn Pathol 2004;21(4):255-9.; Transplant Infections, 3-rd ed. Raleign A. Bowden, Per Ljungman, David R. Snydman. Lippincott Williams & Wilkins, 2010; p. 788.; Transplantation of the Pancreas.; David E.R. Sutherland, Rainer W.G. Gruessner. Springer, 2004; p. 676.; Transplantation Surgery. Nadey S. Hakim and Gabriel M. Danovich. Springer, 2010; p. 450.; Prieto M., Sutherland D.E., FernandezCruz L. et al. Urinary amylase monitoring for early diagnosis of pancreas allograft rejection in dogs. J Surg Res 1986;40(6):597-604.; Groth C.G., Tyden G., Tibell A. Why is the pancreas special? Transplant Proc 1991; 23(4):2183-5.; https://www.jtransplantologiya.ru/jour/article/view/301
-
8Academic Journal
Συγγραφείς: O. N. Rzhevskaya, N. V. Zagorodnikova, K. E. Lazarev, A. V. Pinchuk, О. Н. Ржевская, Н. В. Загородникова, К. Е. Лазарева, А. В. Пинчук
Πηγή: Transplantologiya. The Russian Journal of Transplantation; № 1-2 (2012); 65-69 ; Трансплантология; № 1-2 (2012); 65-69 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2012-0-1-2
Θεματικοί όροι: дислипидемия, a kidney allotransplantation, arterial hypertension, impaired glucose tolerance, cholesterol, dyslipidemia, аллотрансплантация почки, артериальная гипертензия, нарушение толерантности к глюкозе, холестерин
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/382/442; Frederic, I.O. Metabolic syndrome / I.O. Frederic, C.B. Rudra, R.S. Miller // Epidimiology. – 2006. – 17. – P. 428–434.; Алгоритм специализированной медицинской помощи больным сахарным диабетом / под ред. И.И. Дедова, М.В. Шестаковой. – [Б. м.] : [Б. и.], 2007. – 105 с.; Дедов, И.И. Диабетическая нефропатия / И.И. Дедов, М.В. Шестакова. – М. : [Б. и.], 2000. – 220 с.; Paoletti, R. Pharmacological interactions of statins / R. Paoletti, A. Corsini, S. Bellosta // Atherosclerosis. – 2002. – 87. – P. 35–40.; Villegas, R. Prevalence of metabolic syndrome in middle-aged men and women / R. Villegas, I.J. Perry, D. Greagh // Diabetes Care. – 2003. – 26 (11). –P. 3198–3199.; On behalf of the Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators / H. Holdaas [et al.] // Lancet. – 2003. – 361. – P. 2024–2031.; https://www.jtransplantologiya.ru/jour/article/view/382
-
9Academic Journal
Συγγραφείς: K. E. Lasareva, O. N. Rzhevskaya, N. V. Zagorodnikova, К. Е. Лазарева, О. Н. Ржевская, Н. В. Загородникова
Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 9, № 4 (2017); 335-349 ; Трансплантология; Том 9, № 4 (2017); 335-349 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2017-9-4
Θεματικοί όροι: пероральные сахароснижающие препараты, diabetes mellitus, impaired glucose tolerance, tacrolimus, cadaveric kidney allotransplantation, oral hypoglycemic drugs, сахарный диабет, нарушение толерантности к глюкозе, такролимус, аллотрансплантация трупной почки
Περιγραφή αρχείου: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/201/249; Хубутия М.Ш., Ржевская О.Н., Лазарева К.Е. Нарушение метаболизма глюкозы после трансплантации органов. Трансплантология 2009.(2):9–14.; Davidson J., Wilkinson A., Dantal J., et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):SS3–SS24. PMID:12775942 DOI:10.1097/01.TP.0000069952.49242.3E; Wilkinson A., Davidson J., Dotta F., et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin. Transplant. 2005;19(3):291–298. PMID:15877787 DOI:10.1111/j.1399-0012.2005.00359.x; Sharif A. Hecking M., de Vries AP., et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am. J. Transplant. 2014;14(9):1992–2000. PMID:25307034 DOI:10.1111/ajt.12850; Cosio F.G., Kudva Y., van der Velde M., et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67(6):2415–2421. PMID:15882287 DOI:10.1111/j.1523-1755.2005.00349.x; Hecking M., Kainz A., Werzowa J., et al. Glucose metabolism after renal transplantation. Diabetes Care. 2013;36(9):2763–2771. PMID:23656979 DOI:10.2337/dc12-2441; Vincenti F., Friman S., Scheuermann E., et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 2007;7(6):1506–1514. PMID:17359512 DOI:10.1111/j.1600-6143.2007.01749.x; Chakkera H.A., Weil E.J., Pham P.T., et al. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care. 2013;36(10):1406–1412. PMID:24065856; Hornum M., Jørgensen K.A., Hansen J.M., et al. New-onset diabetes mellitus after kidney transplantation in Denmark. Clin. J. Am. Soc. Nephrol. 2010;5(4):709–716. PMID:20167685 DOI:10.2215/CJN.05360709; Voytovich M.H., Simonsen C., Jenssen T., et al. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol. Dial. Transplant. 2005;20(2):413–418. PMID:15615809, DOI:10.1093/ndt/gfh641; Werzowa J., Hecking M., Haidinger M., et al. Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebocontrolled clinical trial. Transplantation. 2013;95(3):456–462. PMID:23380864 DOI:10.1097/TP.0b013e318276a20e; Delaunay F., Khan A., Cintra A., et al. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 1997;1009(8):2094–2098. PMID:9329975 DOI:10.1172/JCI119743; Andrews R.C., Walker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin. Sci. (Lond.). 1999;96(5):513–523. PMID:10209084; Hjelmesaeth J., Hagen L.T., Asberg A., et al. The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol. Dial. Transplant. 2007;22(6):1743–1749. PMID:17299003 DOI:10.1093/ndt/gfl820; Gunnarsson R., Lundgren G., Magnusson G., et al. Steroid diabetes-A sign of overtreatment with steroids in the renal graft recipient? Scand. J. Urol. Nephrol. Suppl. 1980;54:135–138. PMID:7013032; Hjelmesaeth J., Hartmann A., Kofstad J., et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997;64(7):979–983. PMID:9381545; Yang W.C., Chen Y.S, Hsieh W.C., et al. Post-transplant Diabetes Mellitus in Renal Transplant Recipients – Experience in Buddhist Tzu Chi General Hospital. Tzu. Chi. Med. J. 2006;18(3):185–191.; Sumrani N.B., Delaney V., Ding Z.K., et al. Diabetes mellitus after renal transplantation in the cyclosporin era: an analysis of risk factors. Transplantation. 1991;51(2):343–347. PMID:1994525; Boudreaux J.P., McHugh L., Canafax D.M., et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation. 1987;44(3):376–381. PMID:3307061; Von Kiparski A., Fred D., Uhlschmid G., et al. Post-transplant diabetes mellitus in renal allograft recipients: A matchedpair control study. Nephrol. Dial. Transplant. 1990;5(3):220–225. PMID:2113651; Wahlstrom H.E., Akimoto R., Endres D., et al. Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of shortterm cyclosporine treatment. Transplantation. 1992;53(6):1190–1195. PMID:1604471; Gillison S.L., Bartlett S.T., Curry D.L. Inhibition by cyclosporine of insulin secretion – a beta cell-specific alteration of islet tissue function. Transplantation. 1991;52(5):890–895. PMID:1683035; Cosio F.G., Hickson L.J., Griffin M.D., et al. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am. J. Transplant. 2008;8(3):593–599. PMID:18294155 DOI:10.1111/j.1600-6143.2007.02101.x; Hricik D.E., Bartucci M.R., Moir E.J., et al. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation. 1991;51(2):374–377. PMID:1994531; Cosio F.G., Pesavento T.E., Kim S., et al. Patient survival after renal transplantation: IV. Impact of posttransplant diabetes. Kidney Int. 2002;62(4):1440–1446. PMID:12234317 DOI:10.1111/j.1523-1755.2002.kid582.x; Revanur V.K., Jardine A.G., Kingsmore D.B., et al. Influence of diabetes mellitus on patients and graft survival in recipients of kidney transplantation. Clin. Transplant. 2001;15(2):89–94. PMID:11264633; Thomas M.C., Mathew P.H., Russ G.R., et al. Early perioperative glycemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation. 2001;72(7):1321–1324. PMID:11602863; Klahr S., Levey A.S., Beck G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N. Engl. J. Med. 1994;330(13):877–884. PMID:8114857 DOI:10.1056/NEJM199403313301301; Noble N.A., Border W.A. Angiotensin II in renal fibrosis. Should TGFbeta rather than blood pressure be the therapeutic target? Semin Nephrol. 1997;17(5):455–466. PMID:9316214; Sumrani N.B., Delaney V., Ding Z., et al. Diabetes mellitus after renal transplantation in the cyclosporine era : an analysis of risk factors. Transplantation. 1991;51(2):343–347. PMID:1994525; Miles A.M., Sumrani N., Horowitz R., et al. Diabetes mellitus after renal transplantation. Transplantation. 1998;65(3):380–384. PMID:9484755; Lanerolle R.D., de Abrew K., Fernando D.J., Sheriff M.H. Post-renal transplant diabetes in Sri Lanka. Transplant. Proc. 1996;28(10):1945–1947. PMID:8658956; Vesco L., Busson M., Bedrossian J., et al. Diabetes mellitus after renal transplantation. Transplantation. 1996;61(10):1475–1478. PMID:8633374; Raine A.E.G. Cardiovascular complications after renal transplantation. In: ed. Morris P.J. Kidney Transplantation: Principles and Practice. Philadelphia, PA, Saunders, 1988: 575–601.; Schneider D.J., Nordt T.K., Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes. 1993;42(1):1–7. PMID:8420806; Gruessner R.W. Tacrolimus in pancreas transplantation: A multi-center analysis. Tacrolimus Pancreas Study Group. Clin. Transplant. 1997;11(4):299–312. PMID:16298658 DOI:10.1016/j.transproceed.2005.09.020; Von Kiparsky A., Frei D., Uhlschmid G., et al. Post-transplant diabetes mellitus in renal allograft recipients: a matched pair control study. Nephrol. Dial. Transplant. 1990;5(3):220–225. PMID:2113651; Chiu M.Y., Sprague S.M., Bruce D.S., et al. Analysis of fracture prevalence in kidney pancreas allograft recipients. J. Am. Soc. Nephrol. 1998;9(4):677–683. PMID:9555671; Marchetti P. Strategies for risk reduction and management of posttransplant diabetes mellitus. Transplant. Proc. 2001;33(5A Suppl):S27–31. PMID:11498202; Roumie C.L., Hung A.M., Greevy R.A., et al. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann. Intern. Med. 2012;157(9):601–610. PMID:2312885; Thule P.M., Umpierrez G. Sulfonylureas: a new look at old therapy. Curr. Diab. Rep. 2014;14(4):473. PMID:24563333 DOI:10.1007/s11892-014-0473-5; Mocanu M.M., Maddock H.L., Baxter G.F., et al. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation. 2001;103(25):3111–3116. PMID:11425777; Inzucchi S.E. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA. 2002;287(3):360–372. PMID:11790216; Turk T., Pietruck F., Dolff S., et al. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. Am. J. Transplant. 2006;6(4):842–846. PMID:16539642 DOI:10.1111/j.1600-6143.2006.01250.x; Voytovich M.H., Haukereid C., Hjelmesaeth J., et al. Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients. Clin. Transplant. 2007;21(2):246–251. PMID:17425753 DOI:10.1111/j.1399-0012.2006.00634.x; Cusi K., Consoli A., DeFronzo R.A. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1996;81(11):4059–4067. PMID:8923861 DOI:10.1210/jcem.81.11.8923861; Kolata G.B. The phenformin ban: is the drug an imminent hazard? Science. 1979;203(4385):1094–1096. PMID:424735; Shaw J.S., Wilmot R.L., Kilpatrick E.S. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet. Med. 2007;24(10):1160–1163. PMID:17672860 DOI:10.1111/j.1464-5491.2007.02221.x; Kurian B., Joshi, R., Helmuth A. Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients. Endocr Pract. 2008;14(8):979–984. PMID:19095596, DOI:10.4158/EP.14.8.979; Hecking M., Werzowa J., Haidinger M., et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol. Dial. Transplant. 2013;28(3):550–566. PMID:23328712 DOI:10.1093/ndt/gfs583; Sharif A. Should metformin be our antiglycemic agent of choice posttransplantation? Am. J. Transplant. 2011;11(7):1376–1381. PMID:21564529 DOI:10.1111/j.1600-6143.2011.03550.x; Jenssen T., Hartmann A. Emer ging treatments for post-transplantation diabetes mellitus. Nat. Rev. Nephrol. 2015;11(8):465-477. PMID:25917553 DOI:10.1038/nrneph.2015.59; Bajaj M., Suraamornkul S., Pratipanawatr T., et al. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes. 2003;52(6):1364–1370. PMID:12765945; Watkins P.B. Idiosyncratic liver injury: challenges and approaches. Toxicol. Pathol. 2005;33(1):1–5. PMID:15805049 DOI:10.1080/01926230590888306; Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 2007;356(24):2457–2471. PMID:17517853 DOI:10.1056/NEJMoa072761; Luther P., Baldwin D.Jr. Pioglitazone in the management of diabetes mellitus after transplantation. Am. J. Transplant. 2004;49(12):2135–2138. PMID:15575920 DOI:10.1111/j.1600-6143.2004.00613.x; Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors in type 2 diabetes. Lancet. 2006;368(9548):1696–1705. PMID:17098089 DOI:10.1016/S0140-6736(06)69705-5; Haidinger M., Werzowa J., Hecking M., et al. Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation- a randomized, double-blind, placebo-controlled trial. Am. J. Transplant. 2014;14(1):115–123. PMID:24279801; Lane J.T., Odegaard D.E., Haire C.E., et al. Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation. 2011;92(10):e56–e57. PMID:22067216 DOI:10.1097/TP.0b013e3182347ea4; Strom Halden T.A., Asberg A., Vik K., et al. Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol. Dial. Transplant. 2014;29(4):926–933. PMID:24452849 DOI:10.1093/ndt/gft536; Kaakeh Y., Kanjee S., Boone K., Sutton J. Liraglutide-induced acute kidney injury. Pharmacotherapy. 2012;32(1):e7–e11. PMID:22392833 DOI:10.1002/PHAR.1014; Weise W.J., Sivanandy M.S., Block C.A., Comi R.J. Exenatide-associated ischemic renal failure. Diabetes Care. 2009;32(2):e22–e23. PMID:19171732 DOI:10.2337/dc08-1309; Nauck M.A., Del Prato S., DuránGarcía S. et al. Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin. Diabetes Obes. Metab. 2014;16(11):1111–1120. PMID:24919526 DOI:10.1111/dom.12327; Yale J.F. Bakris G., Cariou B., et al. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Diabetes Obes. Metab. 2014;16(10):1016–1027. PMID:24965700 DOI:10.1111/dom.12348; Kohan D.E., Fioretto P., Tang W., List J.F. Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Kidney Int. 2014;85(4):962–971. PMID:24067431 DOI:10.1038/ki.2013.356; Hornum M., Lindahl J.P., von ZurMuhlen B., et al. Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl. Int. 2013;26(11):1049–1060. PMID:23634804 DOI:10.1111/tri.12112; Yates C. J., Fourlanos S., Hjelmesaeth J., et al. New-onset diabetes after kidney transplantation-changes and challenges. Am. J. Transplant. 2012;12(4):820–828. PMID:22123607 DOI:10.1111/j.1600-6143.2011.03855.x; https://www.jtransplantologiya.ru/jour/article/view/201
-
10Academic Journal
Συγγραφείς: KHRYSHCHANOVICH V.Y., VERSHININ P.Y., BOLSHOV A.V., TRETYAK S.I., KUZMENKOVA E.I., PISARENKO A.M., KHODOSOVSKAYA E.V., KOLESNIKOVA T.S., RUMMO O.O.
Περιγραφή αρχείου: text/html
-
11Academic Journal
Συγγραφείς: N. F. Frolova, L. Yu. Artyukhina, E. S. Stolyarevich, Н. Ф. Фролова, Л. Ю. Артюхина, Е. С. Столяревич
Πηγή: Rheumatology Science and Practice; Vol 54, No 1 (2016); 105-107 ; Научно-практическая ревматология; Vol 54, No 1 (2016); 105-107 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20161
Θεματικοί όροι: ритуксимаб, kidney allotransplantation, glomerulonephritis, interstitial lung injury, rituximab, аллотрансплантация почки, гломерулонефрит, интерстициальное поражение легких
Περιγραφή αρχείου: application/pdf
Relation: https://rsp.mediar-press.net/rsp/article/view/2175/1396; Berden A, Ferrario F, Hagen E, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628-36. doi:10.1681/ASN.2010050477; Ferrario F, Vanzati A, Pagni F. Pathology of ANCA-associated vasculitis. Clin Exp Nephrol. 2013;17(5):652-8. doi:10.1007/s10157-012-0701-8; Guillevin L, Pagnoux C, Seror R, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine. 2011;90:19-27. doi:10.1097/MD.0b013e318205a4c6; Бекетова ТВ. Микроскопический полиангиит, ассоциированный с антинейтрофильными цитоплазматическими антителами: особенности клинического течения. Терапевтический архив. 2015;87(5):33-47 [Beketova TV. Microscopic polyangiitis associated with anti-neutrophil cytoplasmic antibody: clinical features. Terapevticheskii arkhiv. 2015;87(5):33-47 (In Russ.)].; Pagnoux C, Hogan S, Chin H, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts. Arthritis Rheum. 2008;58:2908-18. doi:10.1002/art.23800; Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53(12):2306-9. doi:10.1093/rheumatology/ket445; Moran S, Little M. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol. 2014;26(1):37-41. doi:10.1097/BOR.0000000000000006; Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant. 2003;18(5):1001-4. doi:10.1093/ndt/gfg087; Столяревич ЕС, Томилина НА. Эволюция представлений о причинах поздней дисфункции трансплантированной почки. Вестник трансплантологии и искусственных органов. 2015;17(2):113-5 [Stolyarevich ES, Tomilina NA. The evolution of ideas about the causes of late dysfunction of the transplanted kidney. Vestnik transplantologii i iskusstvennykh organov. 2015;17(2):113-5 (In Russ.)].; Stegeman C, Tervaert J, van Son W, Tegzess A. Necrotizing glomerulonephritis associated with antimyeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin. Nephrol Dial Transplant. 1994;9(7):839-42.; Kuross S, Davin T, Kjellstrand CM. Wegener's granulomatosis with severe renal failure: clinical course and results of dialysis and transplantation. Clin Nephrol. 1981;16(4):172-80.; Clarke A, Bitton A, Eappen R, et al. Treatment of Wegener's granulomatosis after renal transplantation: is cyclosporine the preferred treatment? Transplantation. 1990;50(6):1047-51. doi:10.1097/00007890-199012000-00030; Nachman P, Segelmark M, Westman K, et al. Recurrent ANCAassociated small vessel vasculitis after transplantation: A pooled analysis. Kidney Int. 1999;56(4):1544-50. doi:10.1046/j.1523-1755.1999.00666.x; Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 1998;9(7):1258-63.; Gera M, Griffin M, Specks U, et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int. 2007;71(12):1296-301. doi:10.1038/sj.ki.5002244; Geetha D, Seo P. Renal transplantation in the ANCA-associated vasculitides. Am J Transplant. 2007;7(12):2657-62. doi:10.1111/j.1600-6143.2007.01988.x; Murakami C, Manoharan P, Carter-Monroe N, Geetha D. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant. Transpl Int. 2013;26(12):1225-31. doi:10.1111/tri.12203
-
12Academic Journal
Συγγραφείς: СТОЛЯР АЛЕКСЕЙ ГЕННАДЬЕВИЧ
Περιγραφή αρχείου: text/html
-
13Academic Journal
Συγγραφείς: ГАЛКИНА ЕЛЕНА ВАЛЕРЬЕВНА, БЫКОВ АЛЕКСАНДР ЮРЬЕВИЧ, ДЮБАНОВА ГАЛИНА АЛЕКСАНДРОВНА, ТОВ НИКИТА ЛЬВОВИЧ, ПИКАЛОВА НАТАЛЬЯ НИКОЛАЕВНА, МОВЧАН ЕЛЕНА АНАТОЛЬЕВНА
Περιγραφή αρχείου: text/html
-
14Academic Journal
Συγγραφείς: КОРЖЕНЕВСКИЙ А.А., КОРЖЕНЕВСКАЯ Н.П., ЗАГИТОВ А.Р., МУХАМЕДЯНОВ Ф.Н., МЕДВЕДЕВ А.Ю.
Θεματικοί όροι: АЛЛОТРАНСПЛАНТАЦИЯ,ТРУПНАЯ ПОЧКА,ИММУНОСУПРЕССИВНАЯ ТЕРАПИЯ,ALLOTRASPLANTATION,CADAVERIC KIDNEY,IMMUNOSUPRESSIVE THERAPY
Περιγραφή αρχείου: text/html
-
15Academic Journal
Συγγραφείς: АРТЮХИНА ЛЮДМИЛА ЮРЬЕВНА, ИВАНОВА Е.С., ФРОЛОВА Н.Ф., КОТЕНКО О.Н., ШИРИНСКИЙ В.Г., ХОХЛАТОВ Д.Э., VARYASIN В.В., ТОМИЛИНА Н.А.
Θεματικοί όροι: АЛЛОТРАНСПЛАНТАЦИЯ ПОЧКИ, ТУБЕРКУЛЕЗ, ИММУНОСУПРЕССИВНАЯ ТЕРАПИЯ, ХРОНИЧЕСКАЯ ПОЧЕЧНАЯ НЕДОСТАТОЧНОСТЬ
Περιγραφή αρχείου: text/html
-
16Academic Journal
Συγγραφείς: Воробьёва Ольга Васильевна
Θεματικοί όροι: аллотрансплантация костного мозга, катехоламины (КА), серотонин (СТ), гистамин, гранулярные люминесцирующие клетки (ГЛК), тучные клетки (ТК)
Περιγραφή αρχείου: text/html
-
17Academic Journal
Συγγραφείς: S. D. Artamonov, D. A. Velikiy, N. A. Onischenko, L. V. Bashkina, A. O. Nikolskaya, M. E. Krasheninnikov, I. M. Ivanov, С. Д. Артамонов, Д. А. Великий, Н. А. Онищенко, Л. В. Башкина, А. О. Никольская, М. Е. Крашенинников, И. М. Иванов
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 14, № 2 (2012); 86-97 ; Вестник трансплантологии и искусственных органов; Том 14, № 2 (2012); 86-97 ; 1995-1191 ; 10.15825/1995-1191-2012-2
Θεματικοί όροι: аллотрансплантация, immune tolerance, allotransplantation, иммунная толерантность
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/168/110; Артамонов С.Д., Онищенко Н.А., Башкина Л.В. и др. Роль систем врожденного и адаптивного иммунитета в развитии деструктивного иммунного ответа организма на аллотрансплантат // Вестник трансплан- тологии и искусственных органов. 2010. Т. 12, No 3. С. 112–120.; Артамонов С.Д., Онищенко Н.А., Башкина Л.В. и др. Система аутотолерантности и ее функционирование при трансплантации аллогенных органов // Вестник трансплантологии и искусственных органов. 2010. Т. 12, No 3. С. 121–128.; Adeyi O., Fischer S.E., Guindi M. Liver allograft patho- logy: approach to interpretation of needle biopsies with clinicopathological correlation // J. Clin. Pathol. 2010. Vol. 63. P. 47–74.; Azzi J., Sayegh M.H. Clinical Transplantation Tolerance: A myth no more, but // Am. J. Kidney. Dis. 2009. Vol. 54. P. 1005–1011.; Carey E., Carey W.D. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? // Cleveland Clinic Journal of Medicine. 2010. T. 77 (8). P. 519–527.; Codarri L., Vallotton L., Ciuffreda D. et al. Expansion and tissue infiltration of an allospecific CD4+CD25+- CD45RO+IL-7Rαhigh cell population in solid organ transplant recipients // J. Exp. Med. 2007. Vol. 204 (7). P. 1533–1541.; Dan Y.Y., Riehle K.J., Lazaro C. et al. Isolation of mul- tipotent progenitor cells fromhuman fetal liver capable of differentiating into liver and mesenchymal lineages // PNAS. 2006. Vol. 103 (26). P. 9912–9917.; Demirkiran A., Bosma B.M., Kok A. et al. Allosuppres- sive donor CD4+CD25+ regulatory T-cells detach from the graft and circulate in recipients after liver transplan- tation // The Journal of Immunology. 2007. Vol. 178. P. 6066–6072.; Feng S. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable and/or possible? // Curr. Opin. Or- gan. Transplant. 2008. Vol. 13 (5). P. 506–512.; Girlanda R., Kirk A.D. Frontiers in nephrology: immune tolerance to allografts in humans // J. Am. Soc. Nephrol. 2007. Vol. 18. P. 2242–2251.; GoldrathA.W.,BevanM.I.Selectingandmaintainingadi- verse T-cell repertoire // Nature. 1999. Vol. 402. P. 255–262.; Hoehme S., Brulport M., Bauer A. et al. Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regenerati-; on // PNAS. 2010. Vol. 107 (23). P. 10371–10376.; Kawai T., Cosimi A.B., Spitzer T.R. et al. HLA-Mismat- ched renal transplantation without maintenance immu- nosuppression // NEJM. 2008. Vol. l4 (358). P. 353–361.; KleinI.,SatoA.TheHLAsystem.Firstoftwoparts//Ad-; vances in Immunology. 2004. Vol. 343 (10). P. 702–709.; Koshiba T., Li Y., Takemura M. et al. Clinical, immuno- logical, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation // Trans-; plant Immunology. 2007. Vol. 17 (2). P. 94–97.; Krams S.M., Martinez O.M. Epstein Barr virus, rapa- mycin, and host immune responses // Curr. Opin Organ; Transplant. 2008. Vol. 13 (6). P. 563–568.; Li X.C., Turka L.A. An update on regulatory T-cells in transplant tolerance and rejection // Nat. Rev. Nephrol.; Vol. 6. P. 577–583.; Magee J.C. Graft fibrosis in stable pediatric liver trans- plant recipients: What does it mean? // Hepatology. 2009. Vol. 49 (3). P. 726–728.; Mañez R., Kusne S., Linden P. et al. Temporary with- drawal of immunosuppression for life-threatening infec- tions after live transplantation // Transplantation. 1994. Vol. 57 (1). P. 149–151.; Martinez O.M., Rosen H.R. Basic concepts in transplant immunology // Liver Transplantation. 2005. Vol. 11 (4). P. 370–381.; Mazariegos G.V., Reyes J., Marino I.R. et al. Weaning of immunosuppression in liver transplant recipients // Transplantation. 1997. Vol. 63 (2). P. 243–249.; Mazariegos G.V. Immunosuppression withdrawal after liver transplantation: what are the next steps? // Trans- plantation. 2011. Vol. 91. P. 697–699.; Michalopoulos G.K., De Frances M.C. Liver regenerati- on // Science. 1997. Vol. 276 (4). P. 60–66.; Michalopoulos G.K. Liver regeneration // J. Cell. Physi- ol. 2007. Vol. 213 (2). P. 286–300.; Miller D.M., Thornley T.B., Greiner D.L., Rossini A.A. Viral infection: a potent barrier to transplantation tole- rance // Clin. Dev. Immunol. 2008; 2008: 742810.; Morelli A.E., Larregina A.T. Apoptotic cell-based thera- pies against transplant rejection: role of recipient’s dend- ritic cells // Apoptosis. 2010. Vol. 15. P. 1083–1097.; Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance // Nat. Rev. Immu- nol. 2007. Vol. 7 (8). P. 610–621.; Murphy S.P., Porrett P.M., Turka L.A. Innate immunity in transplant tolerance and rejection // Immunol. Rev. 2011. Vol. 241 (1). P. 39–48.; Nafady-Hego H., Li Y., Ohe H. et al. The Generation of donor-specific CD4+CD25+CD45RA+ naive regulatory T-cells in operationally tolerant patients after pediatric li- ving-donor liver transplantation // Transplantation. 2010. Vol. 90. P. 1547–1555.; Nestle F.O., Meglio P.Di., Qin J-Z., Nickoloff B.J. Skin immune sentinels in health and disease // Nat. Rev. Im- munol. 2009. Vol. 9 (10). P. 679–691.; Orlando G., Soker S., Wood K. Operational tolerance after liver transplantation // Hepatology. 2009. Vol. 50. P. 1247–1257.; Page A.J., Ford M.L., Kirk A.D. Memory T-cell-specific therapeutics in organ transplantation // Curr. Opin Organ Transplant. 2009. Vol. 14 (6). P. 643–649.; Reding R., Gras J., Truong D.Q. et al. The Immunolo- gical monitoring of alloreactive responses in liver trans- plant recipients: a review // Liver Transplantation. 2006. Vol. 12. P. 373–383.; Reinherz E.L., Tan K., Tang L. et al. The crystal structure of a T-cell receptor in complex with peptide and MHC class II // Science. 1999. Vol. 286. P. 1913–1921.; Sakaguchi S., Sakaguchi N., Asano M. et al. Immunologic self-tolerance maintained by activated T-cells expressing; IL-2 receptor alpha-chains (CD25): Breakdown of a sing- le mechanism of self-tolerance causes various autoimmu- ne diseases // Immunol. 1995. Vol. 155. P. 1151–1164.; Sebzda E., Mariathasan S., Ohteki T. et al. Selection of the T-cell repertoire // Ann. Rev. Immunol. 1999. Vol. 17. P. 829–874.; Seetharam A., Tiriveedhi V., Mohanakumar T. Alloim- munity and autoimmunity in chronic rejection // Curr. Opin Organ Transplant. 2010. Vol. 15 (4). P. 531–536.; Spada M., Riva S., Maggiore G. et al. Pediatric liver trans- plantation // World J. Gastroenterol. 2009. Vol. 15 (6). P. 648–674.; Starzl T.E., Lakkis F.G. The Unfinished legacy of liver transplantation // Emphasis on Immunology Hepatology. 2006. Vol. 43. P. 151–163.; Starzl T.E. Chimerism and tolerance in transplantation // PNAS. 2004. Vol. 101 (2). P. 14607–14614.; Strick-Marchand H., Masse G.X., Weiss M.C., Di San- to J.P. Lymphocytes support oval cell-dependent liverre- generation // Immunol. 2008. Vol. 181. P. 2764–2771.; Surh C.D., Sprent J. Homeostasis of naive and memory T-cells // Immunity. 2008. Vol. 29. P. 19848–19862.; Takatsuki M., Uemoto S., Inomata Y. et al. Weaning of; immunosuppression in living donor liver transplant reci-; pients // Transplantation. 2001. Vol. 72 (3). P. 449–454.; Tanaka M., Itoh T., Tanimizu N., Miyajima A. Liver stem/ progenitor cells: their characteristics and regulatory me-; chanisms // J. Biochem. 2011. Vol. 149 (3). P. 231–239.; Thomson A.W. Tolerogenic dendritic cells: all present and correct? // Am. J. Transplant. 2010. Vol. 1, 10 (2).; P. 214–219.; Tyden G., Kumlien G., Fehrman I. Successful ABO-; incompatible kidney transplantations without splenec- tomy using antigen-specific immunoadsorption and ritu- ximab // Transplantation. 2003. Vol. 76. P. 730–731.; Ueta H., Shi C., Miyanari N. et al. Systemic transmig- ration of allosensitizing donor dendritic cells to host se- condary lymphoid organs after rat liver transplantation // Hepatology. 2008. Vol. 47 (4). P. 1352–1362.; Van Maren W.W.C., Jacobs J.F.M., de Vries I.J.M. et al. Toll-like receptor signalling on Tregs: to suppress or not to suppress? // Immunology. 2008. Vol. 124. P. 445–452.; Vella J., Neylan J. Why do we need induction therapy? // Sayegh M.H., Remuzzi G., eds. Current and future im- munosuppressive therapies following transplantation. Netherlands, Kluwer academic publisher; 2001. P. 187– 204.; Xia C-Q., Campbell K.A., Clare-Salzler M.J. Extracor- poreal photopheresis-induced immune tolerance: a focu- son modulation of antigen-presenting cells and induction of regulatory T-cells by apoptotic cells // Curr. Opin Or- gan Transplant. 2009. Vol. 14 (4). P. 338–343.; Zheng Z-Y., Weng S-Y., Yu Y. Signal molecule-mediated hepatic cell communication during liver regeneration // World J. Gastroenterol. 2009. Vol. 15. P. 46.; https://journal.transpl.ru/vtio/article/view/168
-
18Academic Journal
Συγγραφείς: V. Ja. Khryshchanovich, S. I. Tretyak, A. N. Kharlamova, T. V. Mochort, E. V. Bogomazova, E. I. Kuzmenkova, V. A. Kondratovich, A. M. Pisarenko, A. V. Romanovich, В. Я. Хрыщанович, С. И. Третьяк, А. Н. Харламова, Т. В. Мохорт, Е. В. Богомазова, Е. И. Кузьменкова, В. А. Кондратович, А. М. Писаренко, А. В. Романович
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 13, № 4 (2011); 60-65 ; Вестник трансплантологии и искусственных органов; Том 13, № 4 (2011); 60-65 ; 1995-1191 ; 10.15825/1995-1191-2011-4
Θεματικοί όροι: паратиреоцит, allotransplantation, parathyroid cell, аллотрансплантация
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/395/336; Alfrey E.J., Perloff L.J., Asplund M.W. et al. Normocal- cemia thirteen years after successful parathyroid allo- grafting in a recipient of a renal transplant // Surgery. 1992. Vol. 111. P. 234.; Cabané P., Oviedo S., Romero C. et al. Primay culture and immortalization of parathyroid cells to cell trans- plant in postsurgical hypoparathyroidism // Rev Chil Cirugı ́a. 2003. Vol. 55. P. 617.; Cabané P., Rossi R., Oviedo S. et al. Establecimiento de la primera linea celular de paratiroides humana // Rev Hospital Clinico U de Chile. 2006. Vol. 17. P. 13.; Cabané P., Gac P., Amat J. et al. Allotransplant of mic- roencapsulated parathyroid tissue in severe postsurgical hypoparathyroidism: a case report // Transplant Proc. 2009. Vol. 41. P. 3879–3883.; Hasse C., Klöck G., Schlosser A. et al. Parathyroid al- lotransplantation without immunosuppression // Lancet. 1997. Vol. 350. P. 1296.; Mallet A., Korbutt G. Alginate modification improves long–term survival and function of transplanted encap- sulated islets // Tissue Eng. 2008. Vol. 14. P. 1.; Sato M., Ma L., Hock J.M. et al. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment // J. Pharmacol Exp. Ther. 2002. Vol. 302. P. 304.; Sollinger H., Mack E., Cook K. et al. Allotransplantation of human parathyroid tissue without immunosupressi- on // Transplantation. 1983. Vol. 36. P. 599.; Tartaglia F., Giuliani A., Sgueglia M. et al. Randomized study on oral administration of calcitriol to prevent sym- ptomatic hypocalcemia after total thyroidectomy // Am. J. Surgery. 2005. Vol. 190. P. 424.; Tolloczko T., Wozniewicz B., Sawicki A. et al. Cultured parathyroid cell transplantation without immunosupres- sion in the treatment of surgical hypoparathyroidism // Tranplant. Proc. 1994. Vol. 26. P. 1901.; Tolloczko T., Wozniewicz B., Sawicki A. et al. Allotrans- plantation of cultured human parathyroid cells: present status and perspectives // Transplant. Proc. 1997. Vol. 29. P. 998.; Torregosa N., Rodrı ́guez J.M., Llorente S. et al. Definitive treatment of persistent hypoparathyroidism: parathyroid allotransplant // Cir. Esp. 2004. Vol. 75. P. 97.; Tretyak S.I., Prochorov A.V., Khryshchanovich V.J. et al. Long-term preservation of vitality of the xenogenic thyrocytes in the recipient after their transplantation into the blood stream // Advances in Medical Sciences. 2008. Vol. 53 (1). P. 76–79.; Ulrich F., Steinmüller T., Rayes N. et al. Cryopreserved human parathyroid tissue: cell cultures for in vitro tes- ting of function // Transplant. Proc. 2001. Vol. 33. P. 666.; Ulrich F., Klupp J., Thurmer F. et al. Allotransplantati- on of encapsulated human parathyroid tissue in patients with permanent hypoparathyroidism // Transplantation. 2004. Vol. 78. P. 79.; Uludag H., De Vos P., Tresco P.A. Technology of mam- malian cell encapsulation // Adv Drug Deliv Rev. 2000. Vol. 42. P. 29.; Zimmermann U., Cramer H., Jork A. et al. Microencap- sulation based cell therapy // In G. Reed, H.-J. Rehm (eds): Biotechnology. 2001. Vol. 10. Weinheim, Germa- ny: Wiley–VCH. P. 547.; Zimmermann U., Thürmer F., Cork A. et al. A novel class of amitogenic alginate microcapsules for long–term im- munoisolated transplantation // Ann. N. Y. Acad. Sci. 2001. Vol. 944. P. 199.; https://journal.transpl.ru/vtio/article/view/395
-
19Academic Journal
Συγγραφείς: A.V. Vatazin, A.B. Zulkarnayev, R.O. Kantarija, M. Krstich, А.В. Ватазин, А.Б. Зулькарнаев, Р.О. Кантария, М. Крстич
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 16, № 2 (2014); 80-87 ; Вестник трансплантологии и искусственных органов; Том 16, № 2 (2014); 80-87 ; 1995-1191 ; 10.15825/1995-1191-2014-2
Θεματικοί όροι: аллотрансплантация трупной почки, антитела, иммуноглобулины, плазмаферез, каскадный плазмаферез
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/206/148; Naesens M., Lerut E., Sarwal M. et al. Balancing efficacy and toxicity of kidney transplant immunosuppression. Transplant Proc. 2009; 41 (8): 3393–3395.; Каабак М.М., Горяйнов В.А., Зокоев А.К. и др. Десятилетний опыт применения раннего плазмафереза после пересадки почки. Вестник трансплантологии и искусственных органов. 2009; 11 (1):28–33. Kaabak M.M., Gorjajnov V.A., Zokoev A.K. et al. Tenyear experience of early plasmapheresis after kidney transplantation. Vestnik transplantologii i iskusstvennyh organov. 2009; 11 (1): 28–33. [In Rus]; Садовников В.И., Сандриков В.А., Каабак М.М. и др. Влияние плазмафереза на функцию и внутриорганный кровоток почечного аллотрансплантата в раннем послеоперационном периоде. Вестник трансплантологии и искусственных органов. 2003; 3:21–30. Sadovnikov V.I., Sandrikov V.A., Kaabak M.M. et al. Effect of plasmapheresis on the function and renal allograft intraorganic blood fl ow in the early postoperative period. Vestnik transplantologii i iskusstvennyh organov. 2003; 3: 21–30. [In Rus]; Shah A., Nadasdy T., Arend L. et al. Treatment of C4dpositive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation. 2004; 77 (9): 1399–1405.; White B. Plasmapheresis in the treatment of acute vascular rejection: an experience on a dialysis unit. J Ren Care. 2006; 32 (4): 208–209.; Bartel G., Schwaiger E., Böhmig G.A. Prevention and treatment of alloantibody-mediated kidney transplant rejection. Transpl Int. 2011; 24 (12): 1142–1155.; Ibernón M., Gil-Vernet S., Carrera M. et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc. 2005; 37 (9): 3743–3745.; Ward D.M. Conventional apheresis therapies: A review. J Clin Apher. 2011; 26 (5): 230–238.; Lennertz A., Fertmann J., Thomae R. et al. Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases. Ther Apher Dial. 2003; 7 (6): 529–535.; Marks S. Therapeutic plasmapheresis: recognizing complications as soon as possible. Pfl ege Z. 2005; 58 (11): 696–698.; Pruijm M.T., Vogt B., Cherpillod A. Plasmapheresis, a safe treatment when applied to the correct indication and with awareness of the complications. Ned. Tijdschr Geneeskd. 2008; 152 (42): 2261–2266.; Gungor O., Sen S., Kircelli F. et al. Plasmapheresis therapy in renal transplant patients: five-year experience. Transplant Proc. 2011; 43 (3): 853–857.; Higgins R., Lowe D., Hathaway M. et al. Double fi ltration plasmapheresis in antibody-incompatible kidney transplantation. Ther Apher Dial. 2010; 14 (4): 392–399.; Tanabe K. Double-filtration plasmapheresis. Transplantation. 2007; 84 (12 Suppl): S30–32.; Matsuo N., Yamamoto H., Kobayashi A. et al. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation. Clin Transplant. 2009; Suppl. 20: 23–26.; Tanabe K., Tokumoto T., Ishida H. et al. ABO-incompatible renal transplantation at Tokyo Women's Medical University. Clin Transpl. 2003; 2003: 175–181.; Uchida J., Iwai T., Kato M. et al. A novel approach to successful ABO-incompatible high-titer renal transplantation. Transplant Proc. 2008; 40 (7): 2285–2288.; https://journal.transpl.ru/vtio/article/view/206
-
20Academic Journal
Θεματικοί όροι: интерстициальное пространство, иммунологическая толерантность, иммунопривилегированность, аллотрансплантация, семенник, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://cryo.net.ua/xmlui/handle/123456789/710
